Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
BD to Expand its Manufacturing Site in Columbus, USA
BD Becton, Dickinson and Company has announced plans to invest US$110 million to expand production of prefillable syringes at its manufacturing site in Columbus
Novartis to Invest US$23 Billion in Florida, USA
Novartis has announced plans to invest US$23 billion to build a radioligand therapy manufacturing facility in Winter Park
Genentech to Invest US$2 Billion in North Carolina, USA
Genentech has announced plans to invest approximately US$2 billion to expand its manufacturing facility in Holly Springs, North Carolina, USA
Sharp Sterile Manufacturing to Invest US$28 Million to Expand Facility in Massachusetts, USA
Sharp Sterile Manufacturing has announced plans to invest US$28 million to expand its facility in Lee, Massachusetts, USA
Alnylam to Invest US$250 Million to Expand RNAi Manufacturing Facility in Massachusetts, USA
Alnylam Pharmaceuticals has announced plans to invest US$250 million to expand its manufacturing facility in Norton, Massachusetts, USA
Samsung Biologics to Invest US$280 Million to Expand Biologics Manufacturing in Maryland
Samsung Biologics has announced plans to invest US$280 million to acquire a biologics manufacturing facility in Rockville, Maryland, USA The Rockville site includes two cGMP manufacturing plants with a combined capacity of 60,000 litres, supporting both clinical and commercial production
INCOG BioPharma to Invest US$200 Million to Expand Injectable Manufacturing Capacity in Indiana
INCOG BioPharma has announced plans to invest approximately US$200 million in expanding its injectable drug product manufacturing facility in Indiana, USA The expansion will increase capacity for injectable drug product manufacturing at the Indiana site The facilities will include additional space
Sharp Services to Invest US$23.3 million (€20 Million) to Expand Injectables Packaging Capacity in Europe
Sharp Services is investing over US$233 million 20 Million to expand injectables packaging capacity at its European facilities in HamontAchel, Belgium, and Heerenveen, The Netherlands
AstraZeneca to Invest US$2 Billion to Expand Biologics and Clinical Manufacturing in Maryland
AstraZeneca has announced plans to invest US$2 billion in expanding its biologics and clinical manufacturing facilities in Maryland, USA
Lilly to Invest US$6.5 Billion to Build State-of-the-Art Active Pharmaceutical Ingredient Manufacturing Facility in Texas
Eli Lilly and Company has announced plans to invest US$65 billion to build a new stateoftheart manufacturing facility at Generation Park in Houston, Texas, USA
